Flagship Plans To Distribute New Fund To About Two Dozen Companies
Executive Appointments Amid Biopharma-Ag Cross-Pollination
The venture capital firm announced a $3.6bn raise for Fund VIII and side funds, which it plans to invest across human health, AI and sustainability-focused companies.
